8 completed, 2 unknown, 1 terminated. 11 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 8, Unknown 2, Terminated 1 |
Follow Paroxysmal Atrial Fibrillation: new trials by email Literature Review of Paroxysmal Atrial Fibrillation trials Research Report on Paroxysmal Atrial Fibrillation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation M201-A Injection, Placebo - Paroxysmal Atrial Fibrillation | Phase 2 | Unknown | Kitasato University | 42 | 2019-05-07 | 2020-10-30 |
| A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation BMS-919373, Placebo (Matching with BMS-919373) - Paroxysmal Atrial Fibrillation | Phase 2 | Terminated | Bristol-Myers Squibb | 158 | 2014-07-25 | 2019-07-31 |
| Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation Pulmonary vein isolation, Botulinum Toxin - Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | Phase 2 | Unknown | Meshalkin Research Institute of Pathology of Circulation | 160 | 2013-06-01 | 2015-09-23 |
| Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation ISIS CRP Rx, Placebo - Paroxysmal Atrial Fibrillation | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 7 | 2012-10-01 | 2015-08-26 |
| Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery botulinum toxin injection, 0.9% normal saline injection, Implantable loop recorder - Paroxysmal Atrial Fibrillation, Indications for CABG | Phase 2 | Completed | Meshalkin Research Institute of Pathology of Circulation | 60 | 2012-09-01 | 2014-01-31 |
| GENESIS Feasibility Study of the BARD Over-the-Wire Mesh Ablation System for the Treatment of Paroxysmal Atrial Fibrillation Catheter Ablation of Paroxysmal Atrial Fibrillation - Paroxysmal Atrial Fibrillation | Phase 2 | Completed | C. R. Bard | 42 | 2011-11-01 | 2013-09-30 |
| Thoracoscopic Versus Endocardial Ablation in Patient With Paroxysmal AF After Failed Initial Endocardial Ablation Thoracoscopic epicardial ablation, Endocardial catheter ablation, Implantable loop recorder - Paroxysmal Atrial Fibrillation | Phase 2 | Completed | Meshalkin Research Institute of Pathology of Circulation | 50 | 2011-05-01 | 2013-03-26 |
| REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation nMARQ™ System - Paroxysmal Atrial Fibrillation | Phase 2 | Completed | Biosense Webster, Inc. | 186 | 2011-03-01 | 2017-06-06 |
| Clinical Evaluation of Therapy™ Cool Flex Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation Therapy™ Cool Flex Ablation Catheter - Paroxysmal Atrial Fibrillation | Phase 2 | Completed | Abbott Medical Devices | 50 | 2010-06-01 | 2019-02-04 |
| Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation CardioFocus HeartLight Endoscopic Ablation System - Paroxysmal Atrial Fibrillation | Phase 2 | Completed | CardioFocus | 100 | 2009-09-01 | 2016-08-01 |
| A Comparison of the Drug Therapy Versus Re-Ablation Anti-Arrhythmia Agents (propafenone, flecainide, and/or sotalol, or amiodarone), re-ablation procedure, ILR implantation - Paroxysmal Atrial Fibrillation, Failed First Radiofrequency Ablation Procedure | Phase 2 | Completed | Meshalkin Research Institute of Pathology of Circulation | 154 | 2007-11-01 | 2012-10-18 |
Atrial Fibrillation (11) · Arrhythmias, Cardiac (1)
Cardiovascular Diseases (11) · Heart Diseases (11) · Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Arrhythmias, Cardiac (10)
Botulinum Toxins (2) · Amiodarone (1) · Anti-Arrhythmia Agents (1) · Feasibility Studies (1) · Flecainide (1) · ISIS 329993 (1) · Propafenone (1) · Radionuclide Generators (1) · Saline Solution (1) · Sotalol (1)
Meshalkin Research Institute of Pathology of Circulation (4) · Abbott Medical Devices (1) · Biosense Webster, Inc. (1) · Bristol-Myers Squibb (1) · C. R. Bard (1) · CardioFocus (1) · Ionis Pharmaceuticals, Inc. (1) · Kitasato University (1)
Russia (4) · Germany (3) · United Kingdom (3) · United States (3) · Canada (2) · France (2) · Italy (2) · Australia (1) · Belgium (1) · Czechia (1) · Denmark (1) · Japan (1) · Portugal (1)
Evgeny Pokushalov, MD, PhD (2) · Burke Barret (1) · David Ciavarella, MD (1) · Evgeny Pokushalov, MD, PhD, FESC (1) · Prof. Pierre Jais, MD (1)